Taken together, these data demonstrated that SFI reduced cell viability, inhibited cell migration and invasion, regulated the cell cycle and apoptosis levels, and controlled the in vitro and in vivo growth state of NSCLC cells by enhancing CHOP-mediated apoptosis activation. The gene discussed is DDIT3; the disease is non-small cell lung carcinoma.